Liposomal Tumor Targeting in Drug Delivery Utilizing MMP-2- and MMP-9-Binding Ligands
Figure 10
Concentrations of doxorubicin in (a) serum and (b) OV-90 xenografts in mice treated with CTT2-SL liposome and Caelyx at 0.5 and 6 hours. Data are represented as a mean of 5 mice ± SD.
